Table 2 Multivariate analysis of clinical variables and WRF
Clinical variables | WRF (-) N = 77 | WRF (+) N = 54 | odds ratio | 95% confidence interval | P value |
|---|---|---|---|---|---|
Positive β1 | 16 (20.1%) | 48 (88.9%) | 51.70 | 14.66, 182.36 | < 0.01 |
Age (years) | 72.4 ± 9.4 | 72.2 ± 8.4 | 0.97 | 0.88, 1.07 | 0.55 |
Male gender | 48 (62.3%) | 35 (64.8%) | 1.10 | 0.28,4.37 | 0.89 |
Body weight (Kg) | 61.0 ± 13.4 | 61.4 ± 12.1 | 1.01 | 0.96,1.06 | 0.95 |
CHF | 32 (41.6%) | 19 (35.2%) | 1.11 | 0.29,4.26 | 0.88 |
Hypertension | 50 (64.9%) | 42 (77.8%) | 7.39 | 1.09,50.01 | 0.04 |
Age (> 75 years) | 33 (42.9%) | 24 (44.4%) | 1.45 | 0.29,7.12 | 0.65 |
Diabetes mellitus | 31 (40.3%) | 28 (51.9%) | 1.32 | 0.37,4.71 | 0.67 |
Stroke | 10 (13.0%) | 9 (16.7%) | 2.16 | 0.41,11.48 | 0.36 |
CHADS2 score ≥ 2 | 49 (63.6%) | 42 (77.8%) | 0.59 | 0.08,4.48 | 0.61 |
Vascular disease | 18 (23.4%) | 13 (24.1%) | 0.95 | 0.21,4.39 | 0.95 |
Persistent AF | 37 (48.1%) | 25 (46.3%) | 1.12 | 0.32,3.86 | 0.86 |
ACE-Is/ARBs | 34 (44.2%) | 21 (38.9%) | 0.47 | 0.13,1.72 | 0.25 |
Diuretics | 26 (33.8%) | 14 (25.9%) | 0.47 | 0.12,1.82 | 0.28 |
LAD (mm) | 43.5 ± 7.7 | 42.9 ± 5.7 | 0.97 | 0.89,1.06 | 0.56 |
LVEF (%) | 63.4 ± 12.3 | 65.2 ± 11.6 | 1.00 | 0.95,1.05 | 0.93 |
Baseline eGFR (mL/min/1.73 m2) | 62.5 ± 18.4 | 62.5 ± 18.4 | 1.01 | 0.96,1.06 | 0.74 |
Baseline CKD class | |||||
G3a, G3b, and G4 | 38 (49.4%) | 20 (37.0%) | 0.79 | 0.15,4.25 | 0.78 |
G1 | 4 (5.2%) | 4 (7.4%) | |||
G2 | 35 (45.5%) | 30 (55.6%) | |||
G3a and G3b | 36 (46.8%) | 19 (35.2%) | |||
G4 | 2 (2.6%) | 1 (1.9%) |